Reply to “Reassessing the Proposed Creatine–PrP Axis in Endometriosis: Methodological and Mechanistic Considerations”
Advanced Science · 2026-08 · 13 (45)
DOI: 10.1002/advs.76708 ↗Kurz gefasst
Leserbrief in der Zeitschrift Advanced Science, online erschienen am 20.07.2026. Verfasst von Siman Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endoc…. Hauptthemen laut MEDLINE: Endometriosis, Creatine. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This Correspondence is a formal response to the Comment by Dr. Machado regarding our publication “Creatine Promotes Endometriosis by Inducing Ferroptosis Resistance via Suppression of PrP.” We address several conceptual concerns raised in the Comment and clarify the physiological relevance of creatine concentrations, the methodological framework for PrP target identification, and the interpretation of human cohort data. We further provide evidence supporting creatine accumulation in endometriotic lesions and peritoneal fluid, and clarify the experimental basis for PrP target identification using integrated biochemical, computational, and functional analyses. Rather than demonstrating a direct molecular interaction, our findings instead provide convergent evidence consistent with PrP acting as a candidate functional target of creatine. We also reinforce the association between creatine exposure, ferroptosis resistance, and lesion progression, while acknowledging that definitive biochemical validation of direct binding remains to be established. Importantly, our study provides translational support for mechanistic investigations in endometriosis, rather than establishing a definitive clinical biomarker. Collectively, we highlight the metabolic significance of creatine–PrP signaling in endometriosis and discuss future directions for mechanistic and clinical validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Obstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Fudan University, Shanghai, People's Republic o…
- Fujian Provincial Key Laboratory of Reproductive Health Research, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Fujian, People's Repu…
- Xinglin College, Nantong University, Nantong, People's Republic of China.
- Department of Reproductive Immunology, The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
- Shanghai Key Laboratory of Embryo Original Diseases, Shanghai, People's Republic of China.
ORCID-Profile: Mingqing Li, Xiaoyong Zhu
Zitieren
APA
Chen, S., Ma, X., Liu, Y., Zhong, Z., Wei, C., Li, M., & Zhu, X. (2026). Reply to “Reassessing the Proposed Creatine–PrP Axis in Endometriosis: Methodological and Mechanistic Considerations”. Advanced Science, 13(45). https://doi.org/10.1002/advs.76708
Vancouver
Chen S, Ma X, Liu Y, Zhong Z, Wei C, Li M, et al. Reply to “Reassessing the Proposed Creatine–PrP Axis in Endometriosis: Methodological and Mechanistic Considerations”. Advanced Science. 2026;13(45). doi:10.1002/advs.76708
BibTeX
@article{Chen2026,
author = {Chen, Siman and Ma, Xiaoqian and Liu, Yukai and Zhong, Zhiqi and Wei, Chunyan and Li, Mingqing and Zhu, Xiaoyong},
title = {Reply to “Reassessing the Proposed Creatine–PrP Axis in Endometriosis: Methodological and Mechanistic Considerations”},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {45},
doi = {10.1002/advs.76708}
}
EUVIMED